DJIA 17,683.58 -46.53 -0.26%
NASDAQ 4,991.94 0.00 0.00%
S&P 500 2,068.76 -8.02 -0.39%
market minute promo

Celgene (NASDAQ: CELG)

118.82 -0.70 (-0.59%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $118.82 -0.59%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $118.42
Previous Close $119.52
Daily Range $117.90 - $120.34
52-Week Range $82.90 - $129.06
Market Cap $94.2B
P/E Ratio 40.93
Dividend (Yield) $0.00 (0.0%)
Volume 3,531,099
Average Daily Volume 4,002,872
Current FY EPS $4.07




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

3 Biotech Stocks Working On CAR-T Immunotherapy You Ought To Watch

Juno Therapeutics, Kite Pharma, and Ziopharm Oncology are developing an entirely new way to battle cancer.

Celgene Rapid Growth Is Still Ahead For 2016 Through 2020

Celgene's Move Into Merck's Former Campus Signals Next Stage Of Growth

Benitec And Bluebird Bio, Gene Therapy Coming Of Age?

Can Celgene Corporation's Superior Earnings Growth Continue?

Celgene has grown earnings far faster than revenue over the past several years. Can they keep it up, or are margins set to peak?

3 Biotech Stocks That Could Grow Faster than Apple

Apple is the king to which all other stocks are compared. However, these three biotech stocks could be poised to trump the tech giant's phenomenal growth rate.

Sector's Smaller Players Show The Way

A $1 Billion Bet on Cancer Cures

Celgene hands $1 Billion to Juno Therapeutics and health insurance on the exchanges will climb 4.4% next year.

Blame the E.U.; Don't Ignore the Good News; ... But Stay Skeptical: Jim Cramer's Best Blogs

Multiple Observations On Celgene's Latest Licensing Deals, And Its Valuation

See More CELG News...

CELG's Top Competitors

CELG $118.82 (-0.59%)
Current stock: CELG
AMGN $154.50 (0.81%)
Current stock: AMGN
GILD $115.66 (0.54%)
Current stock: GILD
$0.00 (0.00%)
Current stock: